Compound details
Rutacridone
| Compound ID | CDAMM00489 |
|---|---|
| Common name | Rutacridone | IUPAC name | 5-hydroxy-11-methyl-2-prop-1-en-2-yl-1,2-dihydrofuro[2,3-c]acridin-6-one |
| Molecular formula | C19H17NO3 |
| Retention time | 7.9 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 308.125 | Theoretical mz | 308.128 |
| Error | 10.96 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.5213 |
| Inchi key | FHAGACMCMQYSNX-UHFFFAOYNA-N |
|---|---|
| Smiles | O=C1C=2C=CC=CC2N(C=3C1=C(O)C=C4OC(C(=C)C)CC43)C |
| Superclass | Organoheterocyclic compounds |
| Class | Quinolines and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P11229 | CHRM1 | Muscarinic acetylcholine receptor M1 | T28893 | SwissTargetPrediction |
| P29274 | ADORA2A | Adenosine A2a receptor | T77365 | SwissTargetPrediction |
| P30542 | ADORA1 | Adenosine A1 receptor | T92072 | SwissTargetPrediction |
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SwissTargetPrediction |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SwissTargetPrediction |
| P09874 | PARP1 | Poly [ADP-ribose] polymerase-1 | T06273 | SwissTargetPrediction |
| P34903 | GABRA3 | GABA A receptor alpha-3/beta-2/gamma-2 | T62292 | SwissTargetPrediction |
| P47869 | GABRA2 | GABA A receptor alpha-2/beta-2/gamma-2 | T51452 | SwissTargetPrediction |
| O15379 | HDAC3 | Histone deacetylase 3 | T05090 | SwissTargetPrediction |
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SwissTargetPrediction |
| P43405 | SYK | Tyrosine-protein kinase SYK | T62431 | SwissTargetPrediction |
| P14867 | GABRA1 | GABA-A receptor; alpha-1/beta-2/gamma-2 | T51487 | SwissTargetPrediction |
| P15121 | AKR1B1 | Aldose reductase | T26623 | SwissTargetPrediction |
| P24864 | CCNE1 | Cyclin-dependent kinase 2/cyclin E1 | T10052 | SwissTargetPrediction |
| P29275 | ADORA2B | Adenosine A2b receptor | T86679 | SwissTargetPrediction |
| P43235 | CTSK | Cathepsin K | T11388 | SwissTargetPrediction |
| P15538 | CYP11B1 | Cytochrome P450 11B1 | T84621 | SwissTargetPrediction |
| P19099 | CYP11B2 | Cytochrome P450 11B2 | T59056 | SwissTargetPrediction |
| Q92769 | HDAC2 | Histone deacetylase 2 | T51191 | SwissTargetPrediction |
| P10275 | AR | Androgen Receptor | T11211 | SwissTargetPrediction |
| Q92731 | ESR2 | Estrogen receptor beta | T80896 | SwissTargetPrediction |
| P45983 | MAPK8 | c-Jun N-terminal kinase 1 | T40097 | SwissTargetPrediction |
| O00519 | FAAH | Anandamide amidohydrolase | T11754 | SwissTargetPrediction |
| Q8NER1 | TRPV1 | Vanilloid receptor | T83193 | SwissTargetPrediction |
| P07339 | CTSD | Cathepsin D | T67102 | SwissTargetPrediction |
| P28845 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | T65200 | SwissTargetPrediction |
| P08253 | MMP2 | Matrix metalloproteinase 2 | T68251 | SwissTargetPrediction |
| P14780 | MMP9 | Matrix metalloproteinase 9 | T54156 | SwissTargetPrediction |
| P03372 | ESR1 | Estrogen receptor alpha | T02506 | SwissTargetPrediction |
| Q13547 | HDAC1 | Histone deacetylase 1 | T68547 | SwissTargetPrediction |
| P14174 | MIF | Macrophage migration inhibitory factor | T39977 | SwissTargetPrediction |
| P09917 | ALOX5 | Arachidonate 5-lipoxygenase | T00140 | SwissTargetPrediction |
| Q9BY41 | HDAC8 | Histone deacetylase 8 | T28887 | SwissTargetPrediction |
| P00338 | LDHA | L-lactate dehydrogenase A chain | T15053 | SwissTargetPrediction |
| P05121 | SERPINE1 | Plasminogen activator inhibitor-1 | T15556 | SwissTargetPrediction |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SwissTargetPrediction |
| P52732 | KIF11 | Kinesin-like protein 1 | T28484 | SwissTargetPrediction |
| P42345 | MTOR | Serine/threonine-protein kinase mTOR | T75243 | SwissTargetPrediction |
| Q9H2K2 | TNKS2 | Tankyrase-2 | T38087 | SwissTargetPrediction |
| O95271 | TNKS | Tankyrase-1 | T83059 | SwissTargetPrediction |
| P14061 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | T44011 | SwissTargetPrediction |
| P00519 | ABL1 | Tyrosine-protein kinase ABL | T63505 | SwissTargetPrediction |
| O60674 | JAK2 | Tyrosine-protein kinase JAK2 | T08391 | SwissTargetPrediction |
| P24941 | CDK2 | Cyclin-dependent kinase 2 | T70176 | SwissTargetPrediction |
| P11802 | CDK4 | Cyclin-dependent kinase 4 | T85799 | SwissTargetPrediction |
| P56817 | BACE1 | Beta-secretase 1 | T79031 | SwissTargetPrediction |
| P45452 | MMP13 | Matrix metalloproteinase 13 | T34296 | SwissTargetPrediction |
| P16050 | ALOX15 | Arachidonate 15-lipoxygenase | T16042 | SwissTargetPrediction |
| P18054 | ALOX12 | Arachidonate 12-lipoxygenase | T35527 | SwissTargetPrediction |
| O14746 | TERT | Telomerase reverse transcriptase | T86052 | SwissTargetPrediction |
| P05093 | CYP17A1 | Cytochrome P450 17A1 | T89041 | SwissTargetPrediction |
| O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | T01003 | SwissTargetPrediction |
| P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | T96623 | SwissTargetPrediction |
| P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | T18477 | SwissTargetPrediction |
| P49810 | PSEN2 | Gamma-secretase | T99204 | SwissTargetPrediction |
| P08581 | MET | Hepatocyte growth factor receptor | T40474 | SwissTargetPrediction |
| P51955 | NEK2 | Serine/threonine-protein kinase NEK2 | T49102 | SwissTargetPrediction |
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SwissTargetPrediction |
| Q15078 | CDK5R1 | Cyclin-dependent kinase 5/CDK5 activator 1 | T09513 | SwissTargetPrediction |
| P25098 | GRK2 | G-protein coupled receptor kinase 2 | T62548 | SwissTargetPrediction |
| O00444 | PLK4 | Serine/threonine-protein kinase PLK4 | T71374 | SwissTargetPrediction |
| Q12884 | FAP | Fibroblast activation protein alpha (by homology) | T53764 | SwissTargetPrediction |
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | T23172 | SwissTargetPrediction |
| Q96EB6 | SIRT1 | NAD-dependent deacetylase sirtuin 1 | T14731 | SwissTargetPrediction |
| P30307 | CDC25C | Dual specificity phosphatase Cdc25C | T40569 | SwissTargetPrediction |
| P07333 | CSF1R | Macrophage colony stimulating factor receptor | T20333 | SwissTargetPrediction |
| P06737 | PYGL | Liver glycogen phosphorylase | T19184 | SwissTargetPrediction |
| P25025 | CXCR2 | Interleukin-8 receptor B | T56923 | SwissTargetPrediction |
| Q9Y5Z0 | BACE2 | Beta secretase 2 | T01280 | SwissTargetPrediction |
| P24557 | TBXAS1 | Thromboxane-A synthase | T78356 | SwissTargetPrediction |
| O76074 | PDE5A | Phosphodiesterase 5A | T07663 | SwissTargetPrediction |
| Q13093 | PLA2G7 | LDL-associated phospholipase A2 | T69912 | SwissTargetPrediction |
| Q99683 | MAP3K5 | Mitogen-activated protein kinase kinase kinase 5 | T97589 | SwissTargetPrediction |
| P04049 | RAF1 | Serine/threonine-protein kinase RAF | T51883 | SwissTargetPrediction |
| P15056 | BRAF | Serine/threonine-protein kinase B-raf | T99089 | SwissTargetPrediction |
| Q12791 | KCNMA1 | Calcium-activated potassium channel subunit alpha-1 | T66538 | SwissTargetPrediction |
| P55201 | BRPF1 | Peregrin | T41145 | SwissTargetPrediction |
| Q07343 | PDE4B | Phosphodiesterase 4B (by homology) | T10265 | SwissTargetPrediction |
| O00408 | PDE2A | Phosphodiesterase 2A | T77400 | SwissTargetPrediction |
| P42226 | STAT6 | Signal transducer and activator of transcription 6 | T20585 | SwissTargetPrediction |
| Q15746 | MYLK | Myosin light chain kinase, smooth muscle | T97141 | SwissTargetPrediction and SEA |
| Q9BUB5 | MKNK1 | MAP kinase-interacting serine/threonine-protein kinase MNK1 | T97136 | SwissTargetPrediction |
| P05129 | PRKCG | Protein kinase C gamma | T47107 | SwissTargetPrediction |
| O60911 | CTSV | Cathepsin (V and K) | T93653 | SEA |
| P01137 | TGFB1 | Transforming growth factor beta-1 | T97257 | SwissTargetPrediction |
| P18507 | GABRG2 | GABA-A receptor; alpha-6/beta-3/gamma-2 | T08910 | SwissTargetPrediction |
| P21462 | FPR1 | Formyl peptide receptor 1 | T87831 | SwissTargetPrediction |
| P16885 | PLCG2 | Phospholipase C-gamma-2 | T93922 | SwissTargetPrediction |
| P19801 | AOC1 | Diamine oxidase | T77546 | SwissTargetPrediction |
| Q9H999 | PANK3 | Pantothenate kinase 3 | T63183 | SwissTargetPrediction |
| Q9H773 | DCTPP1 | dCTP pyrophosphatase 1 | T01249 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T28893 | DI0001 | Abdominal pelvic pain | [ICD-11: MD81] | P11229 | CHRM1 |
| T28893 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P11229 | CHRM1 |
| T28893 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P11229 | CHRM1 |
| T28893 | DI0129 | Dystonic disorder | [ICD-11: 8A02] | P11229 | CHRM1 |
| T28893 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P11229 | CHRM1 |
| T28893 | DI0157 | Gastric ulcer | [ICD-11: DA60] | P11229 | CHRM1 |
| T28893 | DI0166 | Glaucoma | [ICD-11: 9C61] | P11229 | CHRM1 |
| T28893 | DI0186 | Hyperhidrosis | [ICD-11: EE00] | P11229 | CHRM1 |
| T28893 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P11229 | CHRM1 |
| T28893 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P11229 | CHRM1 |
| T28893 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P11229 | CHRM1 |
| T28893 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P11229 | CHRM1 |
| T77365 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P29274 | ADORA2A |
| T77365 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P29274 | ADORA2A |
| T77365 | DI0359 | Radionuclide imaging | [ICD-11: N.A.] | P29274 | ADORA2A |
| T92072 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P30542 | ADORA1 |
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T06273 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P09874 | PARP1 |
| T06273 | DI0143 | Fallopian tube cancer | [ICD-11: 2C74] | P09874 | PARP1 |
| T06273 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P09874 | PARP1 |
| T06273 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P09874 | PARP1 |
| T62292 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P34903 | GABRA3 |
| T51452 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P47869 | GABRA2 |
| T05090 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O15379 | HDAC3 |
| T05090 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O15379 | HDAC3 |
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T62431 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P43405 | SYK |
| T51487 | DI0014 | Acute respiratory distress syndrome | [ICD-11: CB00] | P14867 | GABRA1 |
| T51487 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P14867 | GABRA1 |
| T51487 | DI0082 | Chronic insomnia | [ICD-11: 7A00] | P14867 | GABRA1 |
| T51487 | DI0087 | Chronic pain | [ICD-11: MG30] | P14867 | GABRA1 |
| T51487 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P14867 | GABRA1 |
| T51487 | DI0112 | Cystitis | [ICD-11: GC00] | P14867 | GABRA1 |
| T51487 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14867 | GABRA1 |
| T51487 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P14867 | GABRA1 |
| T51487 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P14867 | GABRA1 |
| T51487 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P14867 | GABRA1 |
| T51487 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P14867 | GABRA1 |
| T51487 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P14867 | GABRA1 |
| T51487 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P14867 | GABRA1 |
| T26623 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P15121 | AKR1B1 |
| T26623 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P15121 | AKR1B1 |
| T86679 | DI0180 | Herpes simplex infection | [ICD-11: 1F00] | P29275 | ADORA2B |
| T86679 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P29275 | ADORA2B |
| T11388 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | P43235 | CTSK |
| T84621 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P15538 | CYP11B1 |
| T84621 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P15538 | CYP11B1 |
| T59056 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P19099 | CYP11B2 |
| T51191 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q92769 | HDAC2 |
| T51191 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q92769 | HDAC2 |
| T11211 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P10275 | AR |
| T11211 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10275 | AR |
| T11211 | DI0021 | Alcoholic liver disease | [ICD-11: DB94] | P10275 | AR |
| T11211 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P10275 | AR |
| T11211 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P10275 | AR |
| T11211 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P10275 | AR |
| T11211 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P10275 | AR |
| T11211 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | P10275 | AR |
| T11211 | DI0247 | Mammary tumour | [ICD-11: 2C60-2C6Z] | P10275 | AR |
| T11211 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P10275 | AR |
| T11211 | DI0401 | Testicular dysfunction | [ICD-11: 5A81] | P10275 | AR |
| T80896 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q92731 | ESR2 |
| T80896 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | Q92731 | ESR2 |
| T80896 | DI0254 | Menopausal disorder | [ICD-11: GA30] | Q92731 | ESR2 |
| T80896 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q92731 | ESR2 |
| T40097 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45983 | MAPK8 |
| T11754 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | O00519 | FAAH |
| T83193 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q8NER1 | TRPV1 |
| T67102 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P07339 | CTSD |
| T65200 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P28845 | HSD11B1 |
| T65200 | DI0239 | Lupus erythematosus | [ICD-11: 4A40] | P28845 | HSD11B1 |
| T65200 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P28845 | HSD11B1 |
| T68251 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08253 | MMP2 |
| T54156 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P14780 | MMP9 |
| T54156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P14780 | MMP9 |
| T54156 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P14780 | MMP9 |
| T54156 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P14780 | MMP9 |
| T02506 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P03372 | ESR1 |
| T68547 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q13547 | HDAC1 |
| T68547 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | Q13547 | HDAC1 |
| T39977 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P14174 | MIF |
| T00140 | DI0037 | Asthma | [ICD-11: CA23] | P09917 | ALOX5 |
| T00140 | DI0147 | Filariasis | [ICD-11: 1F66] | P09917 | ALOX5 |
| T00140 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P09917 | ALOX5 |
| T28887 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9BY41 | HDAC8 |
| T15556 | DI0037 | Asthma | [ICD-11: CA23] | P05121 | SERPINE1 |
| T15556 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P05121 | SERPINE1 |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T28484 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P52732 | KIF11 |
| T28484 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | P52732 | KIF11 |
| T28484 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P52732 | KIF11 |
| T28484 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P52732 | KIF11 |
| T28484 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P52732 | KIF11 |
| T28484 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P52732 | KIF11 |
| T28484 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P52732 | KIF11 |
| T28484 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P52732 | KIF11 |
| T75243 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P42345 | MTOR |
| T75243 | DI0085 | Chronic myelomonocytic leukaemia | [ICD-11: 2A40] | P42345 | MTOR |
| T75243 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P42345 | MTOR |
| T75243 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P42345 | MTOR |
| T75243 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P42345 | MTOR |
| T75243 | DI0413 | Transplant rejection | [ICD-11: NE84] | P42345 | MTOR |
| T38087 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | Q9H2K2 | TNKS2 |
| T83059 | DI0060 | Brain cancer | [ICD-11: 2A00] | O95271 | TNKS |
| T83059 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | O95271 | TNKS |
| T83059 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O95271 | TNKS |
| T83059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O95271 | TNKS |
| T63505 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00519 | ABL1 |
| T63505 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00519 | ABL1 |
| T63505 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P00519 | ABL1 |
| T63505 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P00519 | ABL1 |
| T08391 | DI0039 | Atopic eczema | [ICD-11: EA80] | O60674 | JAK2 |
| T08391 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | O60674 | JAK2 |
| T08391 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | O60674 | JAK2 |
| T08391 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | O60674 | JAK2 |
| T70176 | DI0060 | Brain cancer | [ICD-11: 2A00] | P24941 | CDK2 |
| T70176 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P24941 | CDK2 |
| T70176 | DI0238 | Lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P24941 | CDK2 |
| T70176 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P24941 | CDK2 |
| T70176 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P24941 | CDK2 |
| T70176 | DI0406 | Thymoma | [ICD-11: 2C27] | P24941 | CDK2 |
| T85799 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11802 | CDK4 |
| T85799 | DI0238 | Lung cancer | [ICD-11: 2C25] | P11802 | CDK4 |
| T85799 | DI0351 | Psoriasis | [ICD-11: EA90] | P11802 | CDK4 |
| T79031 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P56817 | BACE1 |
| T34296 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45452 | MMP13 |
| T86052 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | O14746 | TERT |
| T86052 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O14746 | TERT |
| T86052 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14746 | TERT |
| T89041 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P05093 | CYP17A1 |
| T01003 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | O75460 | ERN1 |
| T96623 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P08238 | HSP90AB1 |
| T96623 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08238 | HSP90AB1 |
| T96623 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P08238 | HSP90AB1 |
| T96623 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P08238 | HSP90AB1 |
| T96623 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P08238 | HSP90AB1 |
| T96623 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P08238 | HSP90AB1 |
| T96623 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P08238 | HSP90AB1 |
| T18477 | DI0015 | Acute upper respiratory infection | [ICD-11: CA07] | P07900 | HSP90AA1 |
| T18477 | DI0037 | Asthma | [ICD-11: CA23] | P07900 | HSP90AA1 |
| T99204 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P49810 | PSEN2 |
| T99204 | DI0380 | Shoulder lesion | [ICD-11: FB53] | P49810 | PSEN2 |
| T99204 | DI0390 | Soft tissue disorder | [ICD-11: FB56] | P49810 | PSEN2 |
| T40474 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P08581 | MET |
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T71374 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | O00444 | PLK4 |
| T53764 | DI0300 | Neutropenia | [ICD-11: 4B00] | Q12884 | FAP |
| T23172 | DI0023 | Alopecia | [ICD-11: ED70] | P52333 | JAK3 |
| T23172 | DI0039 | Atopic eczema | [ICD-11: EA80] | P52333 | JAK3 |
| T23172 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P52333 | JAK3 |
| T23172 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P52333 | JAK3 |
| T14731 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q96EB6 | SIRT1 |
| T14731 | DI0399 | Systemic sclerosis | [ICD-11: 4A42] | Q96EB6 | SIRT1 |
| T14731 | DI0431 | Vasculitis | [ICD-11: 4A44] | Q96EB6 | SIRT1 |
| T20333 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P07333 | CSF1R |
| T56923 | DI0155 | Fungal infection | [ICD-11: 1F29-1F2F] | P25025 | CXCR2 |
| T56923 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P25025 | CXCR2 |
| T01280 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | Q9Y5Z0 | BACE2 |
| T78356 | DI0030 | Angina pectoris | [ICD-11: BA40] | P24557 | TBXAS1 |
| T07663 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | O76074 | PDE5A |
| T07663 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | O76074 | PDE5A |
| T07663 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | O76074 | PDE5A |
| T07663 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | O76074 | PDE5A |
| T69912 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q13093 | PLA2G7 |
| T69912 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | Q13093 | PLA2G7 |
| T69912 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | Q13093 | PLA2G7 |
| T97589 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | Q99683 | MAP3K5 |
| T97589 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | Q99683 | MAP3K5 |
| T51883 | DI0252 | Melanoma | [ICD-11: 2C30] | P04049 | RAF1 |
| T51883 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P04049 | RAF1 |
| T51883 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P04049 | RAF1 |
| T51883 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04049 | RAF1 |
| T99089 | DI0252 | Melanoma | [ICD-11: 2C30] | P15056 | BRAF |
| T66538 | DI0037 | Asthma | [ICD-11: CA23] | Q12791 | KCNMA1 |
| T66538 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | Q12791 | KCNMA1 |
| T10265 | DI0037 | Asthma | [ICD-11: CA23] | Q07343 | PDE4B |
| T10265 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | Q07343 | PDE4B |
| T10265 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | Q07343 | PDE4B |
| T77400 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | O00408 | PDE2A |
| T77400 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | O00408 | PDE2A |
| T77400 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | O00408 | PDE2A |
| T77400 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | O00408 | PDE2A |
| T97141 | DI0127 | Duodenal ulcer | [ICD-11: DA63] | Q15746 | MYLK |
| T97136 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q9BUB5 | MKNK1 |
| T97136 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | Q9BUB5 | MKNK1 |
| T97136 | DI0235 | Liver cancer | [ICD-11: 2C12] | Q9BUB5 | MKNK1 |
| T97136 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q9BUB5 | MKNK1 |
| T97136 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9BUB5 | MKNK1 |
| T47107 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P05129 | PRKCG |
| T47107 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P05129 | PRKCG |
| T93653 | DI0055 | Bone cancer | [ICD-11: 2B5Z] | O60911 | CTSV |
| T93653 | DI0087 | Chronic pain | [ICD-11: MG30] | O60911 | CTSV |
| T97257 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P01137 | TGFB1 |
| T08910 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P18507 | GABRG2 |
| T08910 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P18507 | GABRG2 |
| T08910 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P18507 | GABRG2 |
| T87831 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P21462 | FPR1 |
| T63183 | DI0258 | Metabolism inborn error | [ICD-11: 5C50] | Q9H999 | PANK3 |